Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark White

Showing results (111-120 of 115) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 115 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 21, 2024
Phase I Trial of GD2.CART Cells Augmented With Constitutive Interleukin-7 Receptor for Treatment of High-Grade Pediatric CNS TumorsFrank Y Lin, Austin Stuckert, Candise Tat, et al.
Nature|June 4, 2025
Loss of colonic fidelity enables multilineage plasticity and metastasisPatrizia Cammareri, Michela Raponi, Yourae Hong, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 31, 2026
Erratum: Phase I Trial of GD2.CART Cells Augmented With Constitutive Interleukin-7 Receptor for Treatment of High-Grade Pediatric CNS TumorsFrank Y Lin, Austin Stuckert, Candise Tat, et al.
Gut|April 28, 2022
Activation of innate-adaptive immune machinery by poly(I:C) exposes a therapeutic vulnerability to prevent relapse in stroma-rich colon cancerShania M Corry, Amy Mb McCorry, Tamsin Rm Lannagan, et al.
Nature|November 25, 2025
MAPK-driven epithelial cell plasticity drives colorectal cancer therapeutic resistanceMark White, Megan L Mills, Laura M Millett, et al.
Pageof 12

Showing results (111-120 of 115) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 115 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 21, 2024
Phase I Trial of GD2.CART Cells Augmented With Constitutive Interleukin-7 Receptor for Treatment of High-Grade Pediatric CNS TumorsFrank Y Lin, Austin Stuckert, Candise Tat, et al.
Nature|June 4, 2025
Loss of colonic fidelity enables multilineage plasticity and metastasisPatrizia Cammareri, Michela Raponi, Yourae Hong, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 31, 2026
Erratum: Phase I Trial of GD2.CART Cells Augmented With Constitutive Interleukin-7 Receptor for Treatment of High-Grade Pediatric CNS TumorsFrank Y Lin, Austin Stuckert, Candise Tat, et al.
Gut|April 28, 2022
Activation of innate-adaptive immune machinery by poly(I:C) exposes a therapeutic vulnerability to prevent relapse in stroma-rich colon cancerShania M Corry, Amy Mb McCorry, Tamsin Rm Lannagan, et al.
Nature|November 25, 2025
MAPK-driven epithelial cell plasticity drives colorectal cancer therapeutic resistanceMark White, Megan L Mills, Laura M Millett, et al.
Pageof 12